FDA - Search News

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA Approves First New Non-Opioid Pain Pill in Decades

FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

USA TODAY on MSN · 2h

FDA approves new pain medication as an alternative to opioids: What to know about Journavx

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

Newsweek on MSN · 4h

What is Non-Opioid Pain Medication? Journavx Approved by FDA

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

FDA upgrades recall of Lay's potato chips

Newsweek on MSN · 2d

Chocolate Recall Update As FDA Sets Highest Risk Level for 9 States

A recall which was issued across nine states has now been given the highest risk classification by the federal agency.

USA Today · 2d

Lay's potato chips recall upgraded to FDA's most serious level. Is Ohio affected?

The FDA elevated Lay's Classic Potato Chips to the highest risk level. Here what to know, and whether the recall impacts Ohio.

Hosted on MSN · 23h

Lay's potato chips recalled over life-threatening risk as FDA issues warning

Lay recall on Lay's Classic Potato Chips across Oregon and Washington was updated to a Class 1 recall by the FDA on Thursday.

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

19h

US FDA approves Axsome Therapeutics' migraine drug

The U.S. Food and Drug Administration has approved Axsome Therapeutics' migraine treatment, the company said on Thursday.

FDA Recalls Blood Pressure Drug Over ‘Visible Black’ Contaminants

Medicine may not be an exact science, but precision is crucial for patient care. That’s why the presence of unknown particles ...

FDA Opens Up A New Path To The U.S. Market For This Under 30 Biotech Startup

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

STAT8h

How to protect HHS, FDA, NIH, and other health agencies from political interference

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

18h

Axsome Shares Up Post Market After Hitting Record High on FDA Approval

Shares of Axsome Therapeutics rose post-market after the company received approval for Symbravo from the Food and Drug Administration. Symbravo, for the acute treatment of migraine with or without ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

FDA Approves 1st Non-Opioid Pain Drug in 20 Years

FDA upgrades recall of Lay's potato chips

Related topics